The present invention relates to purine compounds that are useful as kinaseInhibitors. More particularly, the presentinvention relates to purine compounds, methods for their preparation,pharmaceutical compositions containing these compounds anduses of these compounds in the treatment of proliferative conditions ordisorders. These compounds may be useful as medicamentsfor the treatment of a number of proliferative conditions or disordersincluding tumours and cancers as well as other disorders orconditions related to or associated with PI3 and/or mTOR kinases. Formula (I).
